Biotech Values

[DonShimoda]

Given that ARIA has gone up after each of the last three financing's, I'm not sure why you are expecting there will be weakness next time. It all depends on the situation/context at the time. If the company is raising $'s to fund a growing world-wide opportunity in multiple wholly-owned drugs then the stock isn't going down. Of course, if they have to raise $'s because the Iclusig sales don't develop as expected then that's a different story but you just said that you "doubt Iclusig will disappoint".